Bayer’s Kerendia was first approved to reduce the risk of kidney function decline, kidney failure, cardiovascular death, non-fatal heart attacks, and hospitalization for heart failure in adults with chronic kidney disease associated with type 2 diabetes in 2021.
2025 US Venture Capital Outlook: Midyear Update
Stop saying ‘sorry’
FDA expands use of Vizamyl
Improve your resume, based on your job search
Merck receives FDA approval for RSV medication
4 expert tips to bounce back after losing your job
Phrases that set introverts apart
Overcoming the 'broken rung'
An interesting look at how women can take control of their careers and beat the broken rung - Click here
Life Sciences Industry in Washington State has Grown 50%
Two job interview red flags
Pfizer halts obesity-drug development
2025 Workforce Trends
Communication experts say people who sound ‘smart and well-spoken’ do these 7 things
Fast-growing skills driving hiring decisions
The top 10 drugs losing exclusivity in the US in 2025
A monthly look at the Life Sciences industry by Outcome Capital
Q4 Revenue boom
In what is described as an ‘always tricky’ Q4, 21 of 22 of the world’s biopharma companies that reported quarterly revenue of at least $2 billion reported an increase in revenue in Q4 of 2024. Leading those increases are Eli Lilly (+45%) and Novo Nordisk (+30%). The only company thus far reporting a decrease is Teva.
GSK receives FDA approval for 5-in-1 meningococcal
Gen Z workers craving more in-person interaction
According to a recent survey of 1,824 U.S. adults in white-collar jobs by Harris Poll on behalf of global events company Freeman, 91% of Gen Z workers say they desire a balance between virtual and in-person opportunities. This will allow them to connect with others at their company and in their industry.